New Partnership to Develop Novel Treatment Approaches Against Infectious Diseases

Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious DiseasesThe new collaboration aims to develop novel breakthrough therapy approaches applying principles of immune modulation to infectious diseases  Immuno-infection is a new focus area of Boehringer Ingelheim ’s Research Beyond Borders (RBB) department, which explores emerging science and technology beyond the company’s core areas of focusBoehringer Ingelheim and Tsinghua University will establish a Joint Research Center for Immuno-Infection for new therapy concept exploration as a joint undertaking that will coordinate collaboration between scientists from the partners and with other academic groups  
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news